Vimarsana
Biggest News Aggregation in the World

Page 9 - Dave Fredrickson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dave Fredrickson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dave Fredrickson Today - Breaking & Trending Today

AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia - Vimarsana News

AstraZeneca Calquence approved in China for chronic lymphocytic leukaemia

Cambridge: AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in China for the treatment of adult patients with chronic...

AstraZeneca Latest to Sue Biden Administration Over IRA's Drug Price Negotiations - Vimarsana News

AstraZeneca Latest to Sue Biden Administration Over IRA's Drug Price Negotiations

The British drugmaker filed a lawsuit on Friday in the U.S. District Court for the District of Delaware claiming the Inflation Reduction Act conflicts with the goals of the Orphan Drug Act.

Biden administration to negotiate costs on Medicare's priciest drugs - Vimarsana News

Biden administration to negotiate costs on Medicare's priciest drugs

For the first time, the federal government is allowed to negotiate drug prices for older Americans. Medicare will name the first 10 drugs by Friday.

Medicare's priciest drugs may get cheaper as feds start negotiations. Big Pharma objects. - Vimarsana News

Medicare's priciest drugs may get cheaper as feds start negotiations. Big Pharma objects.

For the first time, the federal government is allowed to negotiate drug prices for older Americans. Medicare will name the first 10 drugs by Friday.

Source: yahoo.com
AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer - Vimarsana News

AstraZeneca's Lynparza plus abiraterone approved in Japan for treatment of BRCA-mutated metastatic castration-resistant prostate cancer

Cambridge: AstraZeneca and MSD’s Lynparza (olaparib) in combination with abiraterone and prednisolone has been approved in Japan for the treatment of adult patients with BRCA-mutated (BRCAm)...